As much of the U.S. broils in a widespread summer heat spell, the HIV research cauldron boils on -- although its fire is fueled not so much by ambient temperature as by the passions of researchers. In our slate of recently published HIV-related studies this week, we learn that:
- A pair of sexually transmitted infections (STIs), chlamydia and human papillomavirus (HPV), may work synergistically to enhance anal neoplasia risk in people with HIV.
- Predictive modeling may help us identify people who can benefit most from pre-exposure prophylaxis (PrEP).
- Long-term data affirm the liver benefits of curing hepatitis C (HCV) among people with HIV.
- There may be signs of promise for two-drug integrase-based initial therapy.
Wipe your brow, clear the sweat out of your eyes, and let's dip ourselves in the cool, soothing waters of medical data. To beat HIV, you have to follow the science!